Information

2014/02/27

Notice for the drug price and sales commencement for Etuary

2014/02/03

Notice for Exercise of the 37th Round of Stock Options in January, 2014

2014/01/27

Notice for establishment of distributors

2014/01/17

Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option

2014/01/14

Notice for F647 commercial name

2014/01/06

GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China

2014/01/06

（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China

2014/01/06

Notice for Exercise of the 37th Round of Stock Options in December, 2013

2014/01/06

Notice for Large Volume Exercise of the 37th Round of Stock Option

2013/12/06

GNI Group Ltd. Announces a Licensing Agreement for its IPF therapy drug Etuary with AFT Pharmaceuticals for the ASEAN, Australasian and CIS Markets